No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

 Consuelo Walss-Bass, Ph.D., 2004 and 2007 NARSAD Young Investigator Grantee, Associate Professor Department of Psychiatry, University of Texas Health Science Center at San Antonio, Expert on Schizophrenia
Consuelo Walss-Bass, Ph.D.
September 24, 2012
From The Quarterly, Summer 2012 Isolated populations with relatively homogeneous gene pools make excellent natural laboratories for genetic research. One such...
Donald M. Dougherty, Ph.D., William and Marguerite Wurzbach Distinguished Professor, Division of Alcohol and Drug Abuse, Department of Psychiatry, Director, Neurobehavioral Research Laboratory and Clinic, Co-Director, Research Residency Program, University of Texas Health Science Center at San Antonio, Expert on substance abuse, suicide, and mental illness
Donald M. Dougherty, Ph.D.
September 24, 2012
From The Quarterly, Summer 2012 One in five adolescents in the U.S. aged 17 and under uses illicit drugs; one in three drinks alcohol, and of those, one in 10...
Shahrdad Lotfipour, Ph.D., 2003, 2010 NARSAD Young Investigator Grantee, Post-Doctoral Scholar, Department of Psychiatry, University of California, Irvine, Expert on substance abuse
Shahrdad Lotfipour, Ph.D.
September 24, 2012
From The Quarterly, Summer 2012 Cigarettes are among the most addictive agents known. However, tests with laboratory animals suggest this may not be the effect...
Chiara Nosarti, Ph.D., NARSAD Young Investigator Grantee and Expert on Mental Illness from Kings College London
Chiara Nosarti, Ph.D.
September 24, 2012
From The Quarterly, Summer 2012 According to the research of Chiara Nosarti, Ph.D., babies born prematurely appear to have an increased risk for developing...
Robert Malenka, M.D., Ph.D.
Robert Malenka, M.D., Ph.D.
September 24, 2012
From The Quarterly, Summer 2012 In groundbreaking research published this July in the journal Nature, Brain & Behavior Research Foundation Scientific...

Pages

Subscribe to